De Boer R J, Hogeweg P, Dullens H F, De Weger R A, Den Otter W
J Immunol. 1985 Apr;134(4):2748-58.
In this paper we present a model of the macrophage T lymphocyte interactions that generate an anti-tumor immune response. The model specifies i) induction of cytotoxic T lymphocytes, ii) antigen presentation by macrophages, which leads to iii) activation of helper T cells, and iv) production of lymphoid factors, which induce a) cytotoxic macrophages, b) T lymphocyte proliferation, and c) an inflammation reaction. Tumor escape mechanisms (suppression, antigenic heterogeneity) have been deliberately omitted from the model. This research combines hitherto unrelated or even contradictory data within the range of behavior of one model. In the model behavior, helper T cells play a crucial role: Tumors that differ minimally in antigenicity (i.e., helper reactivity) can differ markedly in rejectability. Immunization yields protection against tumor doses that would otherwise be lethal, because it increases the number of helper T cells. The magnitude of the cytotoxic effector cell response depends on the time at which helper T cells become activated: early helper activity steeply increases the magnitude of the immune response. The type of cytotoxic effector cells that eradicates the tumor depends on tumor antigenicity: lowly antigenic tumors are attacked mainly by macrophages, whereas large highly antigenic tumors can be eradicated by cytotoxic T lymphocytes only.
在本文中,我们提出了一个巨噬细胞与T淋巴细胞相互作用的模型,该模型可产生抗肿瘤免疫反应。该模型明确了:i)细胞毒性T淋巴细胞的诱导;ii)巨噬细胞的抗原呈递,这会导致iii)辅助性T细胞的激活;以及iv)淋巴因子的产生,这些淋巴因子可诱导a)细胞毒性巨噬细胞、b)T淋巴细胞增殖和c)炎症反应。肿瘤逃逸机制(抑制、抗原异质性)已被特意排除在该模型之外。本研究将迄今不相关甚至相互矛盾的数据整合到一个模型的行为范围内。在模型行为中,辅助性T细胞起着关键作用:抗原性(即辅助反应性)差异最小的肿瘤,其可排斥性可能有显著差异。免疫接种可提供针对原本会致命的肿瘤剂量的保护,因为它会增加辅助性T细胞的数量。细胞毒性效应细胞反应的强度取决于辅助性T细胞被激活的时间:早期的辅助活性会急剧增加免疫反应的强度。根除肿瘤的细胞毒性效应细胞类型取决于肿瘤抗原性:低抗原性肿瘤主要由巨噬细胞攻击,而大的高抗原性肿瘤只能由细胞毒性T淋巴细胞根除。